Related MeSH Hierarchy (4)
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Signs and Symptoms » Neurologic Manifestations » Neuromuscular Manifestations » Muscle Weakness
Diseases [C] » Musculoskeletal Diseases [C05] » Muscular Diseases » Muscle Weakness
Diseases [C] » Nervous System Diseases [C10] » Neurologic Manifestations » Neuromuscular Manifestations » Muscle Weakness
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Muscle Weakness
Description
A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251) MeSH
Hierarchy View
Subtype Terms (1)
Phase 3 Indicated Drugs (4)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (19)
Organization Involved with Phase 4 Indications (14)
Organization Involved with Phase 3 Indications (36)
Organization Involved with Phase 2 Indications (28)
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (21)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.